Form 8-K - Current report:
SEC Accession No. 0001140361-07-005351
Filing Date
2007-03-09
Accepted
2007-03-08 20:04:06
Documents
3
Period of Report
2007-03-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 2006 EARNINGS RELEASE earningrelease2006.htm 8-K 28415
2 2006 EARNINGS NEWS RELEASE pressrelease2006earnings.htm EX-99.1 19557
3 LOGO biosantelogo6.jpg GRAPHIC 12999
  Complete submission text file 0001140361-07-005351.txt   67671
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 07682251
SIC: 2836 Biological Products, (No Diagnostic Substances)